National Academies Press: OpenBook

Veterans and Agent Orange: Update 11 (2018) (2018)

Chapter: Appendix A: Public Meeting Agendas

« Previous: References
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press. doi: 10.17226/25137.
×

Appendix A

Public Meeting Agendas

FIRST PUBLIC MEETING

March 2, 2017
Keck Center of the National Academies
500 Fifth Street, NW
Washington, DC 20001

Open Session

1:00–1:10 p.m. Welcome and introductions; conduct of the open session
Irva Hertz-Picciotto, Ph.D. – Committee Chair
1:10–2:00 p.m. Charge to the committee and discussion
Peter R. Rumm, M.D., M.P.H. – Director, Pre-9/11 Era Environmental Health Program, Department of Veterans Affairs (VA), with Dr. R. Loren Erickson, Chief Consultant, Post-Deployment Health Services
2:00–2:45 p.m. Overview of VA’s Vietnam Era Health Retrospective Observational Study (VE-HEROeS)
Victoria Davey, Ph.D., M.P.H., R.N. – Principal Investigator, VA
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press. doi: 10.17226/25137.
×
2:45–3:30 p.m. VA Health Care Utilization for Vietnam Veterans
Aaron I. Schneiderman, Ph.D., M.P.H., R.N. – Director, Epidemiology Program Post-Deployment Health Services, VA
3:30–4:30 p.m. Public comments
Thomas Berger, Ph.D., Vietnam Veterans of America
Ann Brazeau, MPN Advocacy and Education International
Carla L. Dean, Bladder Cancer Foundation of Florida
Cindy Fabbri
MSgt LeRoy G. Foster
Raajit K. Rampal, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
Rick Weidman, Vietnam Veterans of America
4:30 p.m. Open session adjourns

SECOND PUBLIC MEETING

September 7, 2017
Courtyard Marriott Bloomington by Mall of America
7800 Bloomington Avenue S.
Lake Hiawatha Room
Bloomington, MN 55425

Open Session

1:00–1:10 p.m. Welcome | Notes on the conduct of the open session | Introduction of participants
Irva Hertz-Picciotto, Ph.D. – Committee Chair
1:10–2:30 p.m. Presentations and comments by participants and questions from the committee
Ronald R. Bach, Ph.D.
Robert Behrens
Richard Bergling
Linda O. Bergum, M.D.
Jeremy Eberley and parents
Maynard Kaderlick
Lee McClary
Mokie Porter
2:30 p.m. Wrap-up and thanks to participants
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press. doi: 10.17226/25137.
×

THIRD PUBLIC MEETING

November 30, 2017
Keck Center of the National Academies
500 Fifth Street, NW
Washington, DC 20001

Open Session

10:15–10:30 a.m. Welcome | Notes on the conduct of the open session | Introduction of participants
Irva Hertz-Picciotto, Ph.D. – Committee Chair
10:30–11:15 a.m. Exposures and Heritable Effects
Thaddeus (Thad) Schug, Ph.D. – Health Scientist Administrator, Population Health Branch, National Institute of Environmental Health Sciences and the National Toxicology Program
11:15 a.m.–12:00 p.m. Russian Children’s Study: Dioxins and Semen Quality
Russ Hauser, Sc.D. – Frederick Lee Hisaw Professor of Reproductive Physiology. Chair, Department of Environmental Health, Harvard T.H. Chan School of Public Health
12:45–1:30 p.m. Multiple Myeloma and its Precursor Disease (MGUS)
C. Ola Landgren, M.D., Ph.D. – Professor of Medicine and Chief Attending Physician of the Myeloma Service, Memorial Sloan Kettering Cancer Center
1:30–2:15 p.m. Epidemiology of Glioma
Quinn T. Ostrom, Ph.D., M.P.H. – Research Coordinator, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine; Research Manager and Primary Analyst, Central Brain Tumor Registry of the United States
2:15–3:00 p.m. Glioblastoma – State of the Science
Paul S. Mischel, M.D. – Member and Head, Laboratory of Molecular Pathology, Ludwig Institute for Cancer Research San Diego and Professor, Department of Pathology, University of California, San Diego
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press. doi: 10.17226/25137.
×
3:00–3:30 p.m. U.S. Department of Veterans Affairs: Vietnam Veterans and Brain Cancer
Ralph L. Erickson, M.D., Dr.P.H., Chief Consultant, Post-Deployment Health Services
Peter D. Rumm, M.D., M.P.H., Director, Pre-9/11 Era Environmental Health Program
3:30–4:00 p.m. Public comments (spoken comments may not exceed 3 minutes per person; written submissions of any length are welcome)
Kathy-Lynn Carroll Josenhans
Robert M. (Bob) Hunter, Ph.D.
Pegi Scarlett
Laurel Smith Holt
4:00 p.m. Open session adjourns
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press. doi: 10.17226/25137.
×
Page 705
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press. doi: 10.17226/25137.
×
Page 706
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press. doi: 10.17226/25137.
×
Page 707
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press. doi: 10.17226/25137.
×
Page 708
Next: Appendix B: Committee and Staff Biographies »
Veterans and Agent Orange: Update 11 (2018) Get This Book
×
Buy Hardback | $115.00 Buy Ebook | $89.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

From 1962 to 1971, the U.S. military sprayed herbicides over Vietnam to strip the thick jungle canopy that could conceal opposition forces, to destroy crops that those forces might depend on, and to clear tall grasses and bushes from the perimeters of US base camps and outlying fire-support bases. Mixtures of 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), picloram, and cacodylic acid made up the bulk of the herbicides sprayed. The main chemical mixture sprayed was Agent Orange, a 50:50 mixture of 2,4-D and 2,4,5-T. At the time of the spraying, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the most toxic form of dioxin, was an unintended contaminant generated during the production of 2,4,5-T and so was present in Agent Orange and some other formulations sprayed in Vietnam.

Because of complaints from returning Vietnam veterans about their own health and that of their children combined with emerging toxicologic evidence of adverse effects of phenoxy herbicides and TCDD, the National Academies of Sciences, Engineering, and Medicine was asked to perform a comprehensive evaluation of scientific and medical information regarding the health effects of exposure to Agent Orange, other herbicides used in Vietnam, and the various components of those herbicides, including TCDD. Updated evaluations were conducted every two years to review newly available literature and draw conclusions from the overall evidence. Veterans and Agent Orange: Update 11 (2018) examines peer-reviewed scientific reports concerning associations between various health outcomes and exposure to TCDD and other chemicals in the herbicides used in Vietnam that were published between September 30, 2014, and December 31, 2017, and integrates this information with the previously established evidence database.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!